Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | IDO1 | P14902 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL538252 | 1.00 | CYP2A6 (0.58) | CYP2A6MAPTIDO1NPSR1CYP1A2 | |
| SCHEMBL9834598 | 1.00 | CYP2A6 (0.58) | CYP2A6MAPTIDO1NPSR1CYP1A2 | |
| SCHEMBL2458425 | 0.90 | CYP2A6 (0.69) | CYP2A6MAPTIDO1NPSR1CYP1A2 | |
| SCHEMBL2458423 | 0.90 | CYP2A6 (0.69) | CYP2A6MAPTIDO1NPSR1CYP1A2 | |
| SCHEMBL26467449 | 0.89 | CYP2A6 (0.55) | CYP2A6MAPTIDO1NPSR1CYP1A2 | |
| SCHEMBL17433423 | 0.86 | CYP2A6 (0.51) | CYP2A6MAPTIDO1NPSR1CYP1A2 | |
| SCHEMBL14386993 | 0.86 | MAPT (0.53) | CYP2A6MAPTIDO1NPSR1CYP1A2 | |
| SCHEMBL18666088 | 0.86 | CYP2A6 (0.51) | CYP2A6MAPTIDO1NPSR1CYP1A2 | |
| SCHEMBL17433424 | 0.83 | AKR1C3 (0.55) | CYP2A6MAPTIDO1NPSR1CYP1A2 | |
| SCHEMBL1177092 | 0.82 | CYP2A6 (0.60) | CYP2A6MAPTIDO1NPSR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102762555-A | Fluorescent cell markers | BEATRIZ BEATRIZ ZAYAS | 2012-10-31 | — | — | CN | claimed |
| US-8124770-B2 | Fluorescent cellular markers | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-28 | — | — | US | claimed |
| US-20100256378-A1 | FLUORESCENT CELLULAR MARKERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-10-07 | — | — | US | claimed |
| US-6403239-B2 | MONOMER CONTAINING PHOTOLUMINESCENCE COMPOUND | BAYER AG (DE) | 2002-06-11 | — | — | US | claimed |
| EP-0767234-B1 | (Co)polymers based on vinyl monomers and their use in electroluminescent devices | BAYER AG (DE) | 2001-12-19 | — | — | EP | claimed |
| EP-0728775-B1 | (Co)polymers based on vinyl monomers and their use in electroluminescent devices | BAYER AG (DE) | 2001-10-04 | — | — | EP | claimed |
| US-20010026879-A1 | (Co)polymers based on vinyl units and use thereof in electroluminescent devices | CHEN YUN (DE) | 2001-10-04 | — | — | US | claimed |
| US-6114463-A | Copolymers based on vinyl units and their use in electroluminescent devices | BAYER AG (DE) | 2000-09-05 | — | — | US | claimed |
| US-6075106-A | (Co)polymers based on vinyl units and use thereof in electroluminescent devices | D-51368 BAYER AG (DE) | 2000-06-13 | — | — | US | claimed |
| US-5891975-A | (Co)polymers based on vinyl units and use thereof in electroluminescent devices | BAYER AKTIENGESELLSCHAFT (DE) | 1999-04-06 | — | — | US | claimed |
| EP-0825207-A2 | (Co)Polymers based on vinyl monomers and their use in electroluminescent devices | BAYER AG (DE) | 1998-02-25 | — | — | EP | claimed |
| EP-0767234-A2 | (Co)polymers based on vinyl monomers and their use in electroluminescent devices | BAYER AG (DE) | 1997-04-09 | — | — | EP | claimed |
| EP-0735055-A2 | Vinyl polymers and copolymers and their use in electroluminescent devices | BAYER AG (DE) | 1996-10-02 | — | — | EP | claimed |
| EP-0728775-A2 | (Co)polymers based on vinyl monomers and their use in electroluminescent devices | BAYER AG (DE) | 1996-08-28 | — | — | EP | claimed |
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) | 2024-02-29 | — | — | US | disclosed |
| US-11786520-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2023-10-17 | — | — | US | disclosed |
| US-11311531-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | SISTEMA UNIV ANA G MENDEZ INC (US) | 2022-04-26 | — | — | US | disclosed |
| EP-0362695-B1 | PYRROLOCARBAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1991-04-03 | — | — | EP | disclosed |
| EP-0362695-A1 | Pyrrolocarbazole derivatives, processes for their preparation and their use as medicaments | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1990-04-11 | — | — | EP | disclosed |
| US-4912107-A | Pyrrolocarbazole derivatives, compositions containing them, and methods for using them | GOEDECKE AKTIENGESELLSCHAFT (DE) | 1990-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11786520-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | CYP2A6 2547/4885MAPT 4399/4885IDO1 1195/4885 |
| US-11311531-B2 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | RECQL, AHNAK, NDUFS1 | CYP2A6 2387/4885MAPT 4449/4885IDO1 1003/4885 |
| US-20100256378-A1 | FLUORESCENT CELLULAR MARKERS | AIFM1, CASP3, BAX | CYP2A6 4465/4885MAPT 3510/4885IDO1 3361/4885 |
| US-20240066023-A1 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | AHNAK, RECQL, NBAS | CYP2A6 2547/4885MAPT 4399/4885IDO1 1195/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.